Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-032935
Filing Date
2013-06-05
Accepted
2013-06-05 16:47:48
Documents
1
Period of Report
2013-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd382255.html 4  
1 FORM 4 rrd382255.xml 4 3774
  Complete submission text file 0001181431-13-032935.txt   5171
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2292 FARADAY AVENUE CARLSBAD CA 92008
Business Address
KISNER DANIEL L (Reporting) CIK: 0001073407 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 13894764